Discovery, Synthesis, and Evaluation of Highly Selective Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) Inhibitor for the Potential Treatment of Metastatic Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Discovery, Synthesis, and Evaluation of Highly Selective Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) Inhibitor for the Potential Treatment of Metastatic Triple-Negative Breast Cancer

Published:2021-08-05 Issue:16 Volume:64 Page:12022-12048
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Li Yang¹^ORCID,Yang Gaoxia¹,Zhang Jifa¹,Tang Pan¹,Yang Chengcan¹,Wang Guan¹^ORCID,Chen Juncheng¹,Liu Jie¹,Zhang Lan²,Ouyang Liang¹^ORCID

Affiliation:

1. State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, China

2. School of Life Science and Engineering, Southwest Jiaotong University Chengdu 610031, China

Funder

Ministry of Education of the People's Republic of China

National Natural Science Foundation of China

Sichuan Science and Technology Program

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c00678

Reference56 articles.